IBDEI13S ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18767,0)
 ;;=E11.349^^82^898^19
 ;;^UTILITY(U,$J,358.3,18767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18767,1,3,0)
 ;;=3^DM 2 w/ SEVERE NPDR w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,18767,1,4,0)
 ;;=4^E11.349
 ;;^UTILITY(U,$J,358.3,18767,2)
 ;;=^5002639
 ;;^UTILITY(U,$J,358.3,18768,0)
 ;;=E11.341^^82^898^18
 ;;^UTILITY(U,$J,358.3,18768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18768,1,3,0)
 ;;=3^DM 2 w/ SEVERE NPDR w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,18768,1,4,0)
 ;;=4^E11.341
 ;;^UTILITY(U,$J,358.3,18768,2)
 ;;=^5002638
 ;;^UTILITY(U,$J,358.3,18769,0)
 ;;=E11.329^^82^898^15
 ;;^UTILITY(U,$J,358.3,18769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18769,1,3,0)
 ;;=3^DM 2 w/ MILD NPDR w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,18769,1,4,0)
 ;;=4^E11.329
 ;;^UTILITY(U,$J,358.3,18769,2)
 ;;=^5002635
 ;;^UTILITY(U,$J,358.3,18770,0)
 ;;=E11.321^^82^898^14
 ;;^UTILITY(U,$J,358.3,18770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18770,1,3,0)
 ;;=3^DM 2 w/ MILD NPDR w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,18770,1,4,0)
 ;;=4^E11.321
 ;;^UTILITY(U,$J,358.3,18770,2)
 ;;=^5002634
 ;;^UTILITY(U,$J,358.3,18771,0)
 ;;=E10.9^^82^898^13
 ;;^UTILITY(U,$J,358.3,18771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18771,1,3,0)
 ;;=3^DM 1 w/o Ophth Manif
 ;;^UTILITY(U,$J,358.3,18771,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,18771,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,18772,0)
 ;;=E10.311^^82^898^1
 ;;^UTILITY(U,$J,358.3,18772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18772,1,3,0)
 ;;=3^DM 1 w/ DR w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,18772,1,4,0)
 ;;=4^E10.311
 ;;^UTILITY(U,$J,358.3,18772,2)
 ;;=^5002592
 ;;^UTILITY(U,$J,358.3,18773,0)
 ;;=E10.319^^82^898^2
 ;;^UTILITY(U,$J,358.3,18773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18773,1,3,0)
 ;;=3^DM 1 w/ DR w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,18773,1,4,0)
 ;;=4^E10.319
 ;;^UTILITY(U,$J,358.3,18773,2)
 ;;=^5002593
 ;;^UTILITY(U,$J,358.3,18774,0)
 ;;=E10.39^^82^898^4
 ;;^UTILITY(U,$J,358.3,18774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18774,1,3,0)
 ;;=3^DM 1 w/ Diabetic Ophthalmic Complication
 ;;^UTILITY(U,$J,358.3,18774,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,18774,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,18775,0)
 ;;=E10.36^^82^898^3
 ;;^UTILITY(U,$J,358.3,18775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18775,1,3,0)
 ;;=3^DM 1 w/ Diabetic Cataract
 ;;^UTILITY(U,$J,358.3,18775,1,4,0)
 ;;=4^E10.36
 ;;^UTILITY(U,$J,358.3,18775,2)
 ;;=^5002602
 ;;^UTILITY(U,$J,358.3,18776,0)
 ;;=E10.359^^82^898^10
 ;;^UTILITY(U,$J,358.3,18776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18776,1,3,0)
 ;;=3^DM 1 w/ PDR w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,18776,1,4,0)
 ;;=4^E10.359
 ;;^UTILITY(U,$J,358.3,18776,2)
 ;;=^5002601
 ;;^UTILITY(U,$J,358.3,18777,0)
 ;;=E10.351^^82^898^9
 ;;^UTILITY(U,$J,358.3,18777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18777,1,3,0)
 ;;=3^DM 1 w/ PDR w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,18777,1,4,0)
 ;;=4^E10.351
 ;;^UTILITY(U,$J,358.3,18777,2)
 ;;=^5002600
 ;;^UTILITY(U,$J,358.3,18778,0)
 ;;=E10.349^^82^898^12
 ;;^UTILITY(U,$J,358.3,18778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18778,1,3,0)
 ;;=3^DM 1 w/ SEVERE NPDR w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,18778,1,4,0)
 ;;=4^E10.349
 ;;^UTILITY(U,$J,358.3,18778,2)
 ;;=^5002599
 ;;^UTILITY(U,$J,358.3,18779,0)
 ;;=E10.341^^82^898^11
 ;;^UTILITY(U,$J,358.3,18779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18779,1,3,0)
 ;;=3^DM 1 w/ SEVERE NPDR w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,18779,1,4,0)
 ;;=4^E10.341
 ;;^UTILITY(U,$J,358.3,18779,2)
 ;;=^5002598
